Complement 3 glomerulopathy (C3G), an ultra‐rare chronic kidney disease, is associated with dysregulation of the alternative complement pathway (AP) in plasma and the glomerular microenvironment, thereby resulting in the accumulation of C3 and its cleavage products in the glomerulus [1, 2]. Here, C3 is linked to complement 3 glomerulopathy.